1. Home
  2. Companies
  3. Cassava Sciences
  4. Financial Ratios
  5. ROA Ratio
Cassava Sciences logo
Cassava Sciences SAVA

Quarterly report 2026-Q1
added 05-07-2026

report update icon

Cassava Sciences ROA Ratio 2011-2026 | SAVA

Annual ROA Ratio Cassava Sciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
-76.86 -15.45 -64.1 -32.47 -12.14 -6.72 -19.72 -32.56 -109.97 -76.94 -44.32 -30.28 62.96 -6.06 -2.64 -12.12 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
62.96 -109.97 -29.96

Quarterly ROA Ratio Cassava Sciences

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-67.14 -70.09 -59.23 -41.43 -24.83 -38.2 -36.84 -39.37 -39.37 -49.14 -41.45 -31.56 -20.44 -22.26 -12.49 -13.73 -6.55 -8.07 -5.78 -5.18 -3.94 -6.91 -9.9 -14.48 -13.26 -19.55 -28.76 -34.98 -29.19 -53.1 -85.22 -98.37 -87.65 -100.71 -95.03 -72.24 -76.94 -78.02 -71.3 -66.25 -44.32 -35.44 -32.57 -29.94 -30.28 -26.53 -18.49 -11.37 -2.94 -5.66 -4.37 -3.72 -2.9 -3.73 -2.21 -2.19 -2.25 -0.82 -1.21 -0.21

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.21 -100.71 -32.33

ROA Ratio of other stocks in the Biotechnology industry

Issuer ROA Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		-241.53 - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		-20.13 - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		-22.19 - 1.35 % $ 17.8 M chinaChina
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		2.77 - - $ 2.02 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		-275.96 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		7.43 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		-41.16 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		3.33 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		23.87 - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
 		-142.36 - -13.47 % $ 169 M franceFrance
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		-8.47 - - $ 2.17 B usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
 		-179.56 - -14.27 % $ 1.7 M singaporeSingapore
AstraZeneca PLC AstraZeneca PLC
AZN
 		8.97 - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
 		20.2 - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		-53.39 - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
 		-114.6 - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
 		-40.14 - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
 		-0.8 - - $ 4.9 B britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
 		2071.28 - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		-35.12 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		-109.04 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		-25.67 $ 49.8 - $ 4.48 B schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		4.82 - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		-77.89 - - $ 231 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		-207.62 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		-43.36 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		-44.38 $ 31.27 - $ 2.08 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		-56.95 - - $ 344 M usaUSA
IMV IMV
IMV
 		-121.19 - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		-30.52 - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
 		-31.09 - 0.23 % $ 488 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		-489.29 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		36.63 - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		-102.69 - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
 		-36.68 - - $ 3.37 B chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
 		-5.72 $ 14.72 - $ 211 M usaUSA
Advaxis Advaxis
ADXS
 		-289.96 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		-48.33 - 5.93 % $ 314 M canadaCanada
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
 		53.1 $ 0.67 - $ 30.6 M israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		-19.95 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		-27.57 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		-19.87 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		-103.3 $ 2.84 - $ 4.68 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
 		-4.87 $ 3.15 - $ 655 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
 		-83.81 $ 17.56 - $ 227 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		-254.37 - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
 		-97.25 - -39.0 % $ 4.57 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
 		-4.99 $ 31.59 - $ 850 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		-11.27 - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
 		-35.68 - 4.14 % $ 49.1 M usaUSA